Molybdenum.

In the gut, molybdenum and sulfur form thiomolybdates that bind copper tightly and hold it in an unabsorbable complex. High molybdenum intake lowers copper status, so formulas carrying both should keep molybdenum near normal intake levels and space the two.

Cysteine from NAC is broken down through sulfite, and sulfite oxidase needs the molybdenum cofactor to finish the step and produce sulfate. Adequate molybdenum keeps that sulfur handling running normally when cysteine intake is high.

Sulfur ends its metabolic route as sulfate, a conversion carried out by the molybdenum enzyme sulfite oxidase. Sulfate also competes with molybdenum for reabsorption in the kidney, so a heavy sulfur load raises molybdenum turnover.

Sulfur compounds are oxidised through sulfite before becoming sulfate, and sulfite oxidase is a molybdenum dependent enzyme. A larger sulfur load raises the call on that enzyme.

Cysteine breakdown passes through sulfite, which sulfite oxidase converts to sulfate using its molybdenum cofactor. Cysteine intake and molybdenum adequacy sit on one pathway.

Xanthine oxidase and aldehyde oxidase each carry FAD alongside their molybdenum cofactor. Riboflavin supplies that FAD, so both nutrients are needed for the enzyme to work.

Xanthine oxidase and aldehyde oxidase contain iron sulfur clusters that pass electrons to and from the molybdenum centre. Iron availability is part of assembling a working enzyme.

Pyridoxal phosphate drives the transsulfuration enzymes that produce cysteine, whose catabolism then needs the molybdenum enzyme sulfite oxidase. The two nutrients sit in sequence on the sulfur pathway.

Glutathione turnover releases cysteine whose sulfur is ultimately oxidised through sulfite to sulfate. That final step depends on the molybdenum cofactor.

Molybdate and selenate are both oxyanions that move on sulfate type transporters, so a high load of one can occupy transport capacity the other uses.

Betaine remethylates homocysteine, which shifts how much sulfur flows down the transsulfuration route toward cysteine and sulfite. Molybdenum handles the last step of that route.

B12 dependent methionine synthase decides how much homocysteine is recycled rather than pushed into transsulfuration. That sets the sulfur load reaching the molybdenum enzyme.

Isothiocyanates from cruciferous material are conjugated to glutathione and progressively degraded, feeding the same sulfur pool that cysteine catabolism does. Sulfite generated along that route is oxidised to sulfate by the molybdenum-dependent enzyme sulfite oxidase. Molybdenum status therefore sits directly behind normal sulfur disposal.

Glucosinolates carry a sulfate group and a thioglucoside sulfur, and their metabolism eventually contributes to the body's sulfite pool. Sulfite oxidase, which carries the molybdenum cofactor, converts sulfite to sulfate for excretion. This is settled cofactor biochemistry rather than a tested combination.

Garlic's organosulfur compounds are broken down to allyl mercaptan and further sulfur species, and the sulfite produced is handled by the molybdenum-dependent sulfite oxidase. The cofactor relationship is established; the practical significance at ordinary garlic intakes has not been quantified.

Methionine is converted through homocysteine to cystathionine and then cysteine, whose catabolism yields sulfite. Sulfite oxidase, a molybdoenzyme, oxidises that sulfite to sulfate. A higher sulfur amino acid load therefore raises the demand on this enzyme.

Cysteine is disposed of either by decarboxylation toward taurine or by oxidation through sulfite to sulfate. The sulfate branch requires the molybdenum cofactor. The two endpoints share an upstream substrate pool, which is why they move together in sulfur metabolism.

S-adenosylmethionine donates a methyl group and becomes homocysteine, which can be routed into transsulfuration toward cysteine. Cysteine catabolism yields sulfite for the molybdenum-dependent sulfite oxidase. The link is a documented metabolic sequence rather than a studied supplement pairing.

Whey carries a high proportion of cysteine and methionine relative to other protein sources, so a large dose increases the sulfur amino acid load presented for catabolism. Sulfite generated along that route is oxidised to sulfate by a molybdenum enzyme. This is composition and pathway biochemistry, not a trial finding.

Xanthine oxidoreductase carries the molybdenum cofactor and converts hypoxanthine to xanthine and then to urate. Flavonoids including quercetin inhibit that enzyme in vitro. The inhibition is on the enzyme, not on molybdenum status, and the effect has been characterised mainly in laboratory assays.

Xanthine oxidoreductase depends on the molybdenum cofactor to produce urate, which is one of the largest reducing species in human plasma. Ascorbate occupies the same antioxidant space. The connection is metabolic rather than a supplement interaction.

Molybdenum is absorbed largely as the molybdate oxyanion, while manganese is absorbed as a divalent cation, so the two do not share a single transporter. What they do share is the general competition among trace minerals in a concentrated multi-mineral dose. The interaction is weaker and less characterised than the molybdenum and copper one.

High-dose zinc is a documented antagonist of copper uptake, and copper in turn interacts strongly with molybdate through thiomolybdate formation. Molybdenum sits inside that three-way trace mineral balance rather than acting independently of it. Direct molybdenum and zinc competition is not well characterised.

Molybdenum is taken up mainly as the molybdate anion, which is stable at neutral to alkaline pH and polymerises to isopolymolybdates as acidity increases. Anything that changes gastric and upper intestinal pH therefore changes the species presented for absorption. The chemistry is well described; the practical effect on absorbed dose is not quantified.

Molybdate, sulfate and phosphate share tetrahedral oxyanion geometry and comparable charge, which is why sulfate transporters accept molybdate. High phosphate loads are a plausible competitor on the same basis. Documented most clearly in plant and microbial systems rather than in people.

Aldehyde oxidase carries the molybdenum cofactor and oxidises a wide range of aza-heterocycles and aldehydes. Pyridine-ring compounds are among its substrate classes. This describes shared enzymology, not an established nutritional interaction between the two supplements.